Table 2. Quality of Surveillance PET and PET-CT studies.
Study | Prospective study design? | Clear eligibility criteria? | Selection bias likely? | Index and reference tests adequately described? | Blinded outcome assessment? | Clear reporting with no discrepancies? | Overall grade |
---|---|---|---|---|---|---|---|
PET-CT | |||||||
| |||||||
Lymphoma | |||||||
| |||||||
Crocchiolo(22) | No | Yes | No | Yes | No | Yes | B |
El-Galaly(23) | No | Yes | No | Yes | No | Yes | B |
| |||||||
Lee(21) | No | Yes | Yes | No | No | Yes | C |
Rhodes(24) | No | Yes | No | Yes | No | Yes | B |
| |||||||
Head and Neck Cancer | |||||||
| |||||||
Abgral(25) | Yes | Yes | No | Yes | Yes | Yes | A |
| |||||||
PET | |||||||
| |||||||
Lymphoma | |||||||
| |||||||
Hosein(27) | No | Yes | Yes | Yes | No | Yes | C |
Zinzani(26) | Yes | Yes | No | Yes | No | No | B |
| |||||||
Head and Neck Cancer | |||||||
| |||||||
Lowe(29) | Yes | Yes | Yes | Yes | Yes | No | B |
Perie(30) | Yes | Yes | Yes | Yes | Yes | Yes | B |
Salaun(31) | No | Yes | No | Yes | Yes | Yes | B |
| |||||||
Colorectal Cancer | |||||||
| |||||||
Selvaggi(28) | No | Yes | Yes | Yes | Yes | Yes | C |
Sobhani(20) | Yes | Yes | No | Yes | Yes | No | B |